| Product Code: ETC9977980 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Theranostics Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Theranostics Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Theranostics Market - Industry Life Cycle |
3.4 United States (US) Theranostics Market - Porter's Five Forces |
3.5 United States (US) Theranostics Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 United States (US) Theranostics Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 United States (US) Theranostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for personalized medicine |
4.2.2 Growing prevalence of chronic diseases |
4.2.3 Technological advancements in diagnostic imaging techniques |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of theranostics products |
4.3.2 High cost associated with theranostics procedures |
4.3.3 Limited awareness among healthcare professionals and patients |
5 United States (US) Theranostics Market Trends |
6 United States (US) Theranostics Market, By Types |
6.1 United States (US) Theranostics Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Theranostics Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 United States (US) Theranostics Market Revenues & Volume, By Polymerase Chain Reaction (PCR), 2021- 2031F |
6.1.4 United States (US) Theranostics Market Revenues & Volume, By Immunohistochemistry (IHC), 2021- 2031F |
6.1.5 United States (US) Theranostics Market Revenues & Volume, By In Situ Hybridization (ISH), 2021- 2031F |
6.1.6 United States (US) Theranostics Market Revenues & Volume, By Sequencing, 2021- 2031F |
6.1.7 United States (US) Theranostics Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United States (US) Theranostics Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Theranostics Market Revenues & Volume, By Oncology, 2021- 2031F |
6.2.3 United States (US) Theranostics Market Revenues & Volume, By Cardiovascular Diseases, 2021- 2031F |
6.2.4 United States (US) Theranostics Market Revenues & Volume, By Neurological Disorders, 2021- 2031F |
6.2.5 United States (US) Theranostics Market Revenues & Volume, By Immunological Disorders, 2021- 2031F |
6.2.6 United States (US) Theranostics Market Revenues & Volume, By Others, 2021- 2031F |
7 United States (US) Theranostics Market Import-Export Trade Statistics |
7.1 United States (US) Theranostics Market Export to Major Countries |
7.2 United States (US) Theranostics Market Imports from Major Countries |
8 United States (US) Theranostics Market Key Performance Indicators |
8.1 Adoption rate of theranostics technologies by healthcare providers |
8.2 Number of clinical trials incorporating theranostics |
8.3 Research and development investment in theranostics technologies |
9 United States (US) Theranostics Market - Opportunity Assessment |
9.1 United States (US) Theranostics Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 United States (US) Theranostics Market Opportunity Assessment, By Application, 2021 & 2031F |
10 United States (US) Theranostics Market - Competitive Landscape |
10.1 United States (US) Theranostics Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Theranostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here